TITLE

Management of asthma exacerbations

AUTHOR(S)
Busse, W. W.; Lemanske, R. F.; Jr.
PUB. DATE
July 2004
SOURCE
Thorax;Jul2004, Vol. 59 Issue 7, p545
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The management of asthma consists of the regular use of anti-inflammatory medications and an action plan for worsening of symptoms or an asthma exacerbation. Guidelines for the treatment of asthma have recommended doubling the dose of maintenance inhaled corticosteroids for deteriorations in asthma control that are not responding to β agonist rescue treatment in the usual manner. the major cause of asthma exacerbations is viral upper respiratory infections. With viral respiratory infections the inflammatory response is more likely to be neutrophilic than eosinophilic, with the latter marker usually predicting a response to inhaled corticosteroids.
ACCESSION #
13997047

 

Related Articles

  • Does use of a corticosteroid/long-acting beta-agonist combination inhaler increase adherence to inhaled corticosteroids? Foden, Jay; Hand, Christopher H. // Primary Care Respiratory Journal;Dec2008, Vol. 17 Issue 4, p246 

    This 12-month retrospective pilot study analysed prescription data of 82 patients with asthma from six practices in Norfolk. Patients on an inhaled corticosteroid/long-acting beta-agonist combination inhaler had significantly greater adherence to inhaled corticosteroids compared to those on a...

  • Doubling the dose of budesonide versus maintainance treatment in asthma exacerbations. Filzgerald, J. M.; Becker, A.; Sears, M. R.; Mink, S.; Chung, K.; Lee, J. // Thorax;Jul2004, Vol. 59 Issue 7, p550 

    Background: Previous guidelines recommend doubling the daily dose of maintenance inhaled corticosteroid to treat or prevent progression of exacerbations of asthma. Methods: Over a 6 month period a cohort of patients were evaluated prospectively and randomised in a double blind controlled trial...

  • Inhaled Corticosteroids: Why Do Physicians and Patients Fail to Comply With Guidelines for Managing Asthma? Reed, Charles E. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p453 

    Points out that failure of physicians to prescribe inhaled corticosteroids for patients with persistent, even mild persistent, asthma has a major adverse impact on the quality of life and healthcare costs. Reasons why physicians do not prescribed inhaled corticosteroids; Disagreement of...

  • Budesonide/Formoterol: A Viewpoint by Paul W. Jones. Jones, Paul W. // Drugs;2004, Vol. 64 Issue 4, p444 

    Budesonide/formoterol is a fixed-dose combination of the corticosteroid budesonide and formoterol, a long-acting J32-agonist, inhaled as a dry powder. Current guidelines for chronic obstructive pulmonary disease (COPD) recommend a long-acting p2-agonist for patients whose symptoms are not...

  • Beclometasone Dipropionate/Formoterol in an HFA-Propelled Pressurised Metered-Dose Inhaler. Barnes, Peter J. // Drugs;2006, Vol. 66 Issue 11, p1484 

    The article reports on the treatment of asthma. The combination of corticosteroid inhalers and B2-agonist are considered the most effective treatments of asthma and in other chronic obstructive pulmonary diseases. Some of the examples of B2-agonists are fluticasone propionate, salmeterol and...

  • Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind Placebo-Controlled Trial. Kemp, James P.; Osur, Scott; Shrewsbury, Stephen B.; Herje, Nancy E.; Duke, Susan P.; Harding, Stuart M.; Faulkner, Kennethf; Crim, Courtney C. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p458 

    • Objective: To evaluate the effects of treatment with fluticasone propionate vs placebo on bone, hypothalamicpituitary-adrenal (HPA) axis function, and the eyes in patients with asthma. • Patients and Methods: This randomized, double-blind, placebo-controlled study of 160 patients...

  • Do Inhaled Corticosteroids Decrease Mortality in COPD? Begany, Timothy // Pulmonary Reviews;Nov2006, Vol. 11 Issue 11, p1 

    The article discusses research being done on the effect of inhaled corticosteroids on mortality rate in chronic obstructive pulmonary disease (COPD). It references a study by K. Wooldrage and colleagues, published in the 2006 issue of "Chest." The methodology and findings of the research are...

  • Salmeterol (Serevent) asthma trial halted early. Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p738 

    Discusses the concerns that the drug Serevent might be associated with life-threatening asthma episodes and asthma-related deaths. Controversy about the safety of long-acting Î’-receptor agonists (LABA); Assessment of white and black patients who used inhaled corticosteroids at baseline;...

  • APRECIERI ASUPRA EFECTELOR ADVERSE ALE CORTICOSTEROIZILOR INHALATORI ADMINISTRAÅ¢I ÃŽN DOZE MICI LA COPIII ASTMATICI. MOHOR, C. // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p103 

    The way in which inhaled corticosteroids influence the growth and the development of the children with asthma is relatively little studied, the results being often contradictory. The study was conducted on two hundred subjects with one hundred children with asthma treated with inhaled...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics